Literature DB >> 15963111

Molecular staging of bladder cancer.

Anirban P Mitra1, Ram H Datar, Richard J Cote.   

Abstract

Attempts are being made in many laboratories to find new biomarkers for and new methods of molecular staging of bladder cancer. At the forefront of this are the authors from Los Angeles who have contributed the first of four mini-reviews in this section. Other mini-reviews examine the role of hand-assisted laparoscopy in urology, a contribution to the sometimes heated argument about whether laparoscopy should be 'pure' or hand-assisted: in addition, two mini-reviews describe the role of photodynamic diagnosis in managing superficial bladder cancer, and the contribution of non-surgical factors to the success of hypospadias repair.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963111     DOI: 10.1111/j.1464-410X.2005.05557.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  21 in total

Review 1.  Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas.

Authors:  Christopher Y Thomas; Dan Theodorescu
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 2.  Molecular substratification of bladder cancer: moving towards individualized patient management.

Authors:  Anirban P Mitra
Journal:  Ther Adv Urol       Date:  2016-03-28

Review 3.  Expression profiling for bladder cancer: strategies to uncover prognostic factors.

Authors:  Georg Bartsch; Anirban P Mitra; Richard J Cote
Journal:  Expert Rev Anticancer Ther       Date:  2010-12       Impact factor: 4.512

4.  17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells.

Authors:  Panagiotis K Karkoulis; Dimitrios J Stravopodis; Lukas H Margaritis; Gerassimos E Voutsinas
Journal:  BMC Cancer       Date:  2010-09-09       Impact factor: 4.430

5.  Generation of a concise gene panel for outcome prediction in urinary bladder cancer.

Authors:  Anirban P Mitra; Vincenzo Pagliarulo; Dongyun Yang; Frederic M Waldman; Ram H Datar; Donald G Skinner; Susan Groshen; Richard J Cote
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

Review 6.  Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

Authors:  Anirban P Mitra; Donna E Hansel; Richard J Cote
Journal:  Semin Oncol       Date:  2012-10       Impact factor: 4.929

7.  Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations.

Authors:  Kerstin Junker; Johanna M M van Oers; Ellen C Zwarthoff; Ines Kania; Joerg Schubert; Arndt Hartmann
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

8.  Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.

Authors:  Erik Pasin; David Y Josephson; Anirban P Mitra; Richard J Cote; John P Stein
Journal:  Rev Urol       Date:  2008

Review 9.  Molecular screening for bladder cancer: progress and potential.

Authors:  Anirban P Mitra; Richard J Cote
Journal:  Nat Rev Urol       Date:  2010-01       Impact factor: 14.432

10.  CD10 expression in urothelial carcinoma of the bladder.

Authors:  Burak Bahadir; Kemal Behzatoglu; Sibel Bektas; Erol R Bozkurt; Sukru O Ozdamar
Journal:  Diagn Pathol       Date:  2009-11-16       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.